We were interested to study the effect of Canagliflozin on podocyte health by quantifying the exosome expression for Nephrin, Wilm’s Tumor (WT-1) and podocalaxyn like protein 1 (PODXL) in urine samples from placebo and Canagliflozin group. This evidence concerns the gene WT1 and Nephroblastoma.